Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus + HCQ vs HCQ + Azithromycin in COVID-19
NCT04374903Phase 2Withdrawn
- Sponsor
- King Hussein Cancer Center
- Start
- Apr 2022
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in coronavirus disease 2019 (COVID-19), sponsored by King Hussein Cancer Center. Planned start Apr 2022; status: withdrawn.
02
Drugs
sirolimus
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04374903.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04374903.